Delcath Systems DCTH HEPZATO KIT — Product revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Delcath Systems in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Delcath Systems’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Delcath Systems's hepzato kit — product revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Delcath Systems's HEPZATO KIT — product revenue?
- Delcath Systems (DCTH) reported HEPZATO KIT — product revenue of $23.25M in Q1 2026.
- How has Delcath Systems's HEPZATO KIT — product revenue changed year-over-year?
- Delcath Systems's HEPZATO KIT — product revenue increased by 29.0% year-over-year, from $18.02M to $23.25M.
- What does HEPZATO KIT — product revenue mean?
- This metric measures the total gross sales generated from the commercialization of a specific product or service line. It reflects the market adoption, pricing power, and commercial success of the offering within its target therapeutic area. Tracking this revenue is essential for evaluating the growth trajectory and financial contribution of a specific business segment.